Remove Government Remove Regulations Remove Trials
article thumbnail

China’s Clinical Trial Boom

Codon

About one-fourth of all clinical trials and early drug development now happens in China. Chinese companies will often run the phase I trial in China for cheap, then flip it to a Western [pharmaceutical company] to run the expensive US trials and bring the drug to market." regulators hoping to speed up drug development, too.

64
article thumbnail

Understanding the Impact of the New EU Artificial Intelligence Act on Clinical Research

Advarra

Artificial intelligence (AI) has taken the world by storm – and regulators are paying attention. These risks face fewer regulations but must meet certain standards to ensure ethical use. High Risk AI-powered Systems: Key Requirements The AI Act will likely consider many AI-based systems used in clinical trials today as “high risk.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

For more than 35 years, Advarra has been committed to protecting the rights and welfare of clinical trial participants while helping to improve healthcare outcomes, advancing medical knowledge, and bringing innovative, life-extending treatments to market that benefit millions of patients worldwide.

article thumbnail

A Look Back as the EU Clinical Trial Regulation Moves Forward

PPD

31, 2022, the EU Clinical Trial Regulation (EU CTR) 536/2014 became applicable, heralding a new era for clinical trials in the European Union (EU). In addition, the constant evolution of EMA and Clinical Trials Coordination Group (CTCG) guidelines requires constant attention.

article thumbnail

The Expansion of Cell Therapies in Asia-Pacific

PPD

There has also been an increase in government and regulatory support for CGT trials, in conjunction with an increase in investments for these products to get to market. The government has also enacted strict trade compliance policies that limit genetic materials, such as patient cells, leaving and entering China.

article thumbnail

The Real Cost of Complexity: What Every Drug Developer Needs to Know

PPD

Cost and complexity go hand-in-hand The rising costs and growing complexity in clinical trials are deeply linked, with patient recruitment, extended timelines and meeting regulatory demands emerging as some of the key drivers. Nearly half (49%) of clinical trial sponsors surveyed identified rising costs as their foremost concern in 2024.

article thumbnail

Revolutionizing Pharma: The Strategic Guide to AI Deployment

DrugBank

This tech can speed up everything from drug design to clinical trials by processing complex datasets more efficiently. Focus on building robust systems to manage and analyze a vast array of data types, ensuring top-notch data governance and quality. Data Management: AI thrives on data. In the U.S.,